Murae Organisor Ltd vs Welcure Drugs Pharmaceuticals Ltd Stock Comparison

Home

Insights

Stock Comparison

Last Updated on: Oct 25, 2026

Key Highlights

The Latest Trading Price of Murae Organisor Ltd is ₹ 0.19 as of 25 Mar 15:30 . The P/E Ratio of Murae Organisor Ltd changed from 15.1 on March 2022 to 17.3 on March 2025 . This represents a CAGR of 3.46% over 4 yearsThe P/E Ratio of Welcure Drugs & Pharmaceuticals Ltd changed from 37.6 on March 2021 to 47.8 on March 2025 . This represents a CAGR of 4.92% over 5 years The Market Cap of Murae Organisor Ltd changed from ₹ 33.43 crore on March 2022 to ₹ 128.27 crore on March 2025 . This represents a CAGR of 39.96% over 4 yearsThe Market Cap of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ 2.54 crore on March 2021 to ₹ 102.13 crore on March 2025 . This represents a CAGR of 109.35% over 5 years The revenue of Murae Organisor Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 0 crore. This represent the decline of 0% The revenue of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 revenue of ₹ 1.46 crore. This represent the decline of -100% The ebitda of Murae Organisor Ltd for the Mar '26 is ₹ 0 crore as compare to the Dec '25 ebitda of ₹ 0 crore. This represent the decline of 0% The ebitda of Welcure Drugs & Pharmaceuticals Ltd for the Mar '26 is ₹ -49.86 crore as compare to the Dec '25 ebitda of ₹ 1.43 crore. This represent the decline of -3586% The net profit of Murae Organisor Ltd changed from ₹ -0.24 crore to ₹ 0 crore over 8 quarters. This represents a CAGR of -100.00% The net profit of Welcure Drugs & Pharmaceuticals Ltd changed from ₹ -0.34 crore to ₹ -49.86 crore over 8 quarters. This represents a CAGR of 1110.98% The Dividend Payout of Murae Organisor Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 yearsThe Dividend Payout of Welcure Drugs & Pharmaceuticals Ltd changed from 0 % on March 2021 to 0 % on March 2025 . This represents a CAGR of 0.0% over 5 years .

About Murae Organisor Ltd

Murae Organisor Ltd Quarterly Results Overview Murae Organisor Ltd reports its quarterly results, which cover important financial factors such as revenue, profit, and the company’s overall performance in each quarter.
It helps users understand how the company has been performing over time and provides an idea of business trends across different periods.
Additionally, Murae Organisor quarterly results help investors understand key market movements and any changes that may impact the company’s financial performance. Key Metrics of Murae Organisor Ltd Quarterly Result The key metrics of the Murae Organisor quarterly results are as follows: Revenue This is the total income generated by the company from its business operations during the quarter.
It indicates the overall sales performance and shows the scale of business activity.
Investors often compare revenue trends across periods, such as Murae Organisor Q1 results, Murae Organisor Q2 results, and so on, to understand growth patterns. Net Profit Profit after tax is the amount of earnings left after all expenses, interest and taxes are subtracted.

About Welcure Drugs & Pharmaceuticals Ltd

Incorporated on 4th June, 1992, Welcure Drugs And Pharmaceuticals Limited(WDPL) was promoted by D C Jain, Sanjeev Jain and Sandeep Jain.
The promoters have interests in other companies such as Paam Pharmaceuticals, Pioneer Products, Alirox Abrasives, A K Laboratories, etc. WDPL had come out with a Rs 4-cr public issue in Aug.'94 to part-finance the Rs 12 Crore project to manufacture bulk drugs in Rajasthan and finance investments in a subsidiary, A K Laboratories (AKL).
The company has also submitted the letter of offer for a Rs 7.09-cr rights issue of equity shares in Jan.'96 to finance its expansion programmes. Products of WDPL include bulk drugs such as ampicillin and trimethoprim, drugs intermediates and pharmaceutical formulations.
It has decided to add amoxycillin and cloxacillin to its range with provision to manufacture ibuprofen.

FAQs for the comparison of Murae Organisor Ltd and Welcure Drugs & Pharmaceuticals Ltd

Which company has a larger market capitalization, Murae Organisor Ltd or Welcure Drugs & Pharmaceuticals Ltd?

Market cap of Murae Organisor Ltd is 38 Cr while Market cap of Welcure Drugs & Pharmaceuticals Ltd is 22 Cr

What are the key factors driving the stock performance of Murae Organisor Ltd and Welcure Drugs & Pharmaceuticals Ltd?

The stock performance of Murae Organisor Ltd and Welcure Drugs & Pharmaceuticals Ltd is primarily driven by its robust global client base, consistent revenue growth, strong operational efficiency, strategic investments in digital transformation, client acquisition, and the overall health of the industry. Both companies' performances are also influenced by macroeconomic conditions, currency fluctuations, and industry-specific trends.

What are the recent stock price for Murae Organisor Ltd and Welcure Drugs & Pharmaceuticals Ltd?

As of October 25, 2026, the Murae Organisor Ltd stock price is INR ₹0.19. On the other hand, Welcure Drugs & Pharmaceuticals Ltd stock price is INR ₹0.18.

How do dividend payouts of Murae Organisor Ltd and Welcure Drugs & Pharmaceuticals Ltd compare?

To compare the dividend payouts of Murae Organisor Ltd and Welcure Drugs & Pharmaceuticals Ltd, examine their dividend payout ratio, which indicates how much the companies pay out relative to their share price and earnings. Moreover, consider the consistency and growth of their dividends to gauge their commitment towards returning value to the respective shareholders.

Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.